|
Biomarkers of Risk for Colorectal Neoplasia
|
|
Schoen, Robert E.
|
|
Biomarkers of Risk for Colorectal Neoplasia (Team Project #2)
|
Investigators in the colon section of EDRN have a mutual interest in developing markers that would identify individuals at increased risk for colon neoplasia. ... |
Schoen, Robert E.
|
|
Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non- progressing cancers
|
We hypothesize that our novel Biomarker Panel of Auto-antibodies can distinguish aggressive, symptom diagnosed lung cancer from non-aggressive, screen-detected ... |
Rom, William
|
|
Biomarkers to Distinguish Aggressive Cancers from Non-aggressive or Non-progressing Cancer
|
Distinguishing aggressive cancers from non-aggressive or non-progressing cancers is an issue of both clinical
and public health importance particularly for ... |
Li, Christopher
|
|
Body Fluids as a Source of Diagnostic Biomarkers
|
|
Semmes, John
|
|
Body Fluids as a Source of Diagnostic Biomarkers: Breast
|
|
Semmes, John
|
|
Body Fluids as a Source of Diagnostic Biomarkers: Prostate
|
Recent advances in high-throughput protein expression profiling of bodily fluids has generated great enthusiasm and hope for this approach as a potent ... |
Semmes, John
|
|
Breast Cancer: subgroups specific blood-biomarkers for early / predictive diagnosis and personalized treatment
|
Breast-conserving lumpectomy followed by radiation therapy has been shown to be an alternative strategy, competitive to mastectomy, in preventing mortality ... |
Golubnitschaja, Prof. Dr. Olga
|
|
Breast Ductal Lavage Fluid Specimen Bank
|
|
Trock, Bruce
|
|
Breast Ref Set Applicant: Anu Mathew-Meso Scale 2012
|
|
Mathew, Anu
|
|
Breast Reference Set Applicant-Tuszynski-Temple (2012)
|
|
Feng, Ziding
|
|
Breast Reference Set Applicant:- Zangar-Pacific NW Nat'l Laboratory
|
|
Feng, Ziding
|
|
Breast tissue array
|
|
Chia, David
|
|
CLUE Studies: Evaluating Biomarkers of Carcinogenesis
|
|
Helzlsouer, Kathy
|
|
Canary TMA
|
|
Nelson, Peter S
|
|
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients
|
BACKGROUND:
Carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC-Ag), and CYFRA 21-1 are the most useful markers for non-small cell lung ... |
Kulpa, Jan
|
|
Chemokine Prostate Cancer Biomarkers
|
STUDY DESIGN
1. The need for pre-validation studies. Preliminary data from our laboratory demonstrates a potential utility for CXCL5 and CXCL12 as biomarkers ... |
Macoska, Jill
|
|
Clinical Proteomic Technologies for Cancer Initiative (CPTAC) Phase I
|
CPTAC Phase I 2006 - 2011, was developed to address the pre-analytical and analytical variability issues that are major barriers to the field of proteomics. ... |
Kinsinger, Chris
|
|
Clinical Proteomic Technologies for Cancer Initiative (CPTAC) Phase II
|
The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC). |
Kinsinger, Chris
|
|
Clinical Utility of Urinary CD90 as a Biomarker for Prostate Cancer Detection
|
Tumor-associated stromal cells differ from normal gland-associated stromal cells in gene expression. Genes up-regulated in these stromal cells are potential ... |
Liu, Alvin Y.
|
|
Clinical Validation of Molecular Signatures of Cervical Neoplasia
|
|
Unger, Elizabeth R.
|
|
Clinical and Analytical Validation of Cancer Biomarkers: Developmental Studies
|
|
Chan, Daniel
|
|
Clinical validation of an autoantibody test for lung cancer
|
BACKGROUND:
Autoantibodies may be present in a variety of underlying cancers several years before tumours can be detected and testing for their presence may ... |
Boyle, Peter
|
|
Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
|
Identification of molecular markers often leads to important clinical applications such as early diagnosis, prognosis, and drug targeting. Lung cancer, the ... |
Kim, Bumjin
|
|
Collaborative study on SELDI biomarker discovery and serum protein profiling of lung cancers
|
|
Semmes, John
|
|
Colon Cancer Specimen Reference Set Application: Disis - University of Washington (2008)
|
The proposed study aims to validate the diagnostic value of a panel of serum antibodies for the early detection of colorectal cancer (CRC). We have developed a ... |
Disis, Mary L
|
|
Colon Cancer Specimen Reference Set Application: Getzenberg - Johns Hopkins (2008)
|
The goal of this project is to confirm the early validation of CCSA-3 and CCSA-4 as biomarkers for the early detection of adenocarcinoma of the colon and ... |
Getzenberg, Robert H.
|
|
Colon Cancer Specimen Reference Set Application: Jendoubi - Milagen (2006)
|
No Data Received at DMCC |
Jendoubi, Moncef
|
|
Colon Cancer Specimen Reference Set Application: Kim - DiaDexus (2008)
|
|
Kim, Nam
|
|
DCIS Team Project
|
|
Li, Christopher
|
